UBcare. Co. Ltd (032620) - Cash Flow Conversion Efficiency
Based on the latest financial reports, UBcare. Co. Ltd (032620) has a cash flow conversion efficiency ratio of 0.001x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩184.89 Million ≈ $125.29K USD) by net assets (₩159.99 Billion ≈ $108.42 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see UBcare. Co. Ltd market cap and net worth for the company's overall valuation and market capitalisation.
UBcare. Co. Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)
This chart illustrates how UBcare. Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
UBcare. Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of UBcare. Co. Ltd ranked by their cash flow conversion efficiency. Explore UBcare. Co. Ltd earnings quality ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Star Holdings
NASDAQ:STHO
|
-0.030x |
|
Gossamer Bio Inc
NASDAQ:GOSS
|
0.439x |
|
Daesung Ind
KO:128820
|
0.002x |
|
Cartier Resources Inc
V:ECR
|
-0.014x |
|
Bogota Financial Corp
NASDAQ:BSBK
|
0.002x |
|
Protech Mitra Perkasa Tbk PT
JK:OASA
|
-0.061x |
|
PT Buana Artha Anugerah Tbk
JK:STAR
|
-0.003x |
|
Seer Inc
NASDAQ:SEER
|
-0.042x |
Annual Cash Flow Conversion Efficiency for UBcare. Co. Ltd (2011–2025)
The table below shows the annual cash flow conversion efficiency of UBcare. Co. Ltd from 2011 to 2025. View current stock price of UBcare. Co. Ltd for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩158.89 Billion ≈ $107.68 Million |
₩16.63 Billion ≈ $11.27 Million |
0.105x | +342.05% |
| 2024-12-31 | ₩99.22 Billion ≈ $67.24 Million |
₩2.35 Billion ≈ $1.59 Million |
0.024x | +7.93% |
| 2023-12-31 | ₩113.54 Billion ≈ $76.94 Million |
₩2.49 Billion ≈ $1.69 Million |
0.022x | -39.77% |
| 2022-12-31 | ₩116.70 Billion ≈ $79.09 Million |
₩4.25 Billion ≈ $2.88 Million |
0.036x | -45.93% |
| 2021-12-31 | ₩117.89 Billion ≈ $79.89 Million |
₩7.94 Billion ≈ $5.38 Million |
0.067x | -39.01% |
| 2020-12-31 | ₩106.52 Billion ≈ $72.19 Million |
₩11.76 Billion ≈ $7.97 Million |
0.110x | -3.89% |
| 2019-12-31 | ₩102.57 Billion ≈ $69.51 Million |
₩11.79 Billion ≈ $7.99 Million |
0.115x | +39.13% |
| 2018-12-31 | ₩101.66 Billion ≈ $68.90 Million |
₩8.40 Billion ≈ $5.69 Million |
0.083x | -58.86% |
| 2017-12-31 | ₩46.55 Billion ≈ $31.55 Million |
₩9.35 Billion ≈ $6.33 Million |
0.201x | +198.71% |
| 2016-12-31 | ₩46.56 Billion ≈ $31.55 Million |
₩3.13 Billion ≈ $2.12 Million |
0.067x | -60.94% |
| 2015-12-31 | ₩45.31 Billion ≈ $30.70 Million |
₩7.80 Billion ≈ $5.28 Million |
0.172x | +30.76% |
| 2014-12-31 | ₩39.49 Billion ≈ $26.76 Million |
₩5.20 Billion ≈ $3.52 Million |
0.132x | +4.66% |
| 2011-12-31 | ₩47.23 Billion ≈ $32.01 Million |
₩5.94 Billion ≈ $4.02 Million |
0.126x | -- |
About UBcare. Co. Ltd
UBcare. Co., Ltd. provides health care solutions in South Korea and internationally. The company offers medical IT services, such as Ysarang, an EMR system for hospital/clinic use; and U Pharm, an integrated management control system for pharmacies, hospitals, clinics, and pharmacy environments; and Big Ysarang, an EMR system for small and medium-sized hospitals, as well as customer management an… Read more